av/bright-minds-biosciences--big.svg

NASDAQ:DRUG

Bright Minds Biosciences Inc.

  • Stock

USD

Last Close

1.45

23/07 17:48

Market Cap

6.12M

Beta: 1.25

PE Ratio

−1.30

PFCF: −1.69

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Sep '19
Sep '20
Sep '21
Sep '22
Sep '23
average inventory
average payables
367.50K
-
921.48K
150.74%
714.35K
22.48%
average receivables
55.07K
-
132.96K
141.43%
96.38K
27.51%
book value per share
0.10
-
0.63
533.97%
10.81
1,615.95%
0.85
92.10%
capex per share
capex to depreciation
capex to operating cash flow
capex to revenue
cash per share
0.06
-
0.69
1,006.30%
11.01
1,493.31%
0.94
91.45%
days of inventory on hand
days payables outstanding
days sales outstanding
debt to assets
0.01
-
0.01
7.63%
debt to equity
0.01
-
0.01
16.01%
dividend yield
earnings yield
-0.00
-
-0.01
582.94%
-0.10
969.00%
-0.14
37.81%
enterprise value
54.67M
-
48.69M
10.94%
61.37M
26.03%
93.50M
52.37%
-6.67M
107.14%
enterprise value over ebitda
-694.48
-
-103.74
85.06%
-7.01
93.25%
-6.35
9.44%
0.91
114.35%
ev to operating cash flow
-1.30K
-
-168.83
87.03%
-8.38
95.03%
-6.88
17.92%
0.95
113.81%
ev to sales
free cash flow per share
-0.03
-
-0.25
659.46%
-4.08
1,537.01%
-1.10
73.03%
free cash flow yield
-0.00
-
-0.01
659.46%
-0.09
1,448.28%
-0.13
43.44%
graham net net
0.03
-
0.56
1,558.80%
10.70
1,808.57%
0.83
92.28%
graham number
0.37
-
2.44
558.00%
33.97
1,292.65%
4.86
85.70%
income quality
0.53
-
0.60
12.49%
0.85
40.93%
0.91
7.31%
0.95
4.94%
intangibles to total assets
0.00
-
0.00
18,528.50%
0.00
95.61%
0
100%
0
interest coverage
-66.17
-
interest debt per share
0.03
-
inventory turnover
invested capital
0.01
-
0.01
16.01%
market cap
54.75M
-
49.49M
9.61%
81.13M
63.92%
104.99M
29.42%
net current asset value
43.28K
-
727.29K
1,580.32%
19.40M
2,567.40%
10.40M
46.37%
6.53M
37.22%
net debt to ebitda
1.02
-
1.70
67.72%
2.26
32.38%
0.78
65.45%
0.91
16.83%
net income per share
-0.06
-
-0.42
582.94%
-4.74
1,030.26%
-1.23
74.08%
operating cash flow per share
-0.03
-
-0.25
659.46%
-4.08
1,537.01%
-1.10
73.03%
payables turnover
receivables turnover
research and ddevelopement to revenue
return on tangible assets
-0.48
-
-0.55
15.26%
-0.42
23.20%
-1.26
195.69%
-1.07
14.71%
revenue per share
roe
-0.62
-
-0.67
7.72%
-0.44
34.13%
-1.44
228.24%
-1.12
22.44%
roic
-0.62
-
-0.65
5.57%
-0.44
31.75%
-1.38
211.11%
-1.10
20.79%
sales general and administrative to revenue
shareholders equity per share
0.10
-
0.63
533.97%
10.81
1,615.95%
0.85
92.10%
stock based compensation to revenue
tangible asset value
127.26K
-
727.29K
471.50%
19.40M
2,567.40%
10.54M
45.66%
6.60M
37.41%
tangible book value per share
0.10
-
0.63
533.97%
10.81
1,615.95%
0.85
92.10%
working capital
43.28K
-
727.29K
1,580.32%
19.40M
2,567.40%
10.48M
46.00%
6.53M
37.65%

All numbers in USD (except ratios and percentages)